21 results
8-K
EX-10.1
AVRW
Avenir Wellness Solutions, Inc.
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
or coverage under, any Benefit Plan or collective bargaining agreement that would increase the annual expense of maintaining such plan above the level … , amend, modify or terminate any Benefit Plan or any collective bargaining agreement.
(i) Each Benefit Plan that is subject to Section 409A of the Code
8-K
EX-10.1
mfnx5m02bi57bkcby0
2 Nov 20
CURE Pharmaceutical Closes $10 Million Financing
4:05pm
8-K
EX-2.1
1eul1060yc3x 2x
5 Oct 20
Entry into a Material Definitive Agreement
8:16am
8-K/A
EX-2.1
8j8vo
31 Dec 19
Completion of Acquisition or Disposition of Assets
12:15pm